Loading…
Please register to continue your trial period!
meRfi-GM provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
In the context of Gemcitabine & Pancreatic Ductal Adenocarcinoma (PDAC) / Pancreatic Cancer, for the U.S., gemcitabine injection is FDA‑approved as first‑line treatment for patients with locally advanced or metastatic Pancreatic Ductal Adenocarcinoma (PDAC) / Pancreatic Cancer and gemcitabine has been a standard‑of‑care backbone for decades in exocrine pancreatic cancer (1).
Gemcitabine is also centrally authorized in the EU for for the treatment of locally advanced or metastatic Pancreatic Ductal Adenocarcinoma (PDAC) / Pancreatic Cancer (2).
A study, utilizing data from the SE…